scispace - formally typeset
L

Lena Setchanova

Researcher at Sofia Medical University

Publications -  24
Citations -  296

Lena Setchanova is an academic researcher from Sofia Medical University. The author has contributed to research in topics: Streptococcus pneumoniae & Pneumococcal conjugate vaccine. The author has an hindex of 10, co-authored 24 publications receiving 231 citations.

Papers
More filters
Journal ArticleDOI

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Bulgarian Hospitals

TL;DR: Plasmid fingerprinting and random amplified polymorphic DNA analysis typing revealed wide dissemination of identical plasmids among different bacterial species and hospitals, as well as clonal spread of ESBL producers.
Journal ArticleDOI

Comparison of culture method and real-time PCR for detection of putative periodontopathogenic bacteria in deep periodontal pockets

TL;DR: Better sensitivity of the real-time PCR, when compared to the microbiological culture method, was demonstrated, in regards to the detection of the periodontal pathogens, and the lower detection levels of the cultivation methods may be explained by the problems of keeping pathogenic bacteria viable.
Journal ArticleDOI

Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines.

TL;DR: The levels of antibiotic resistance among S. pneumoniae and H. influenzae causing severe AOM in children are high in the authors' settings and the existence of multidrug-resistant S. coronavirus pneumoniae serotype 19A is of particular concern.
Journal ArticleDOI

Global landscape review of serotype-specific invasive pneumococcal disease surveillance among countries using PCV10/13: The pneumococcal serotype replacement and distribution estimation (PSERENADE) project

Maria Deloria Knoll, +75 more
TL;DR: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project as discussed by the authors evaluated the global evidence to estimate the impact of 10-and 13-valent pneumococcal conjugate vaccines by age, product, schedule, and syndrome.
Journal ArticleDOI

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project.

Maria Garcia Quesada, +52 more
TL;DR: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project described the serotype distribution of remaining pneumococcal meningitis in countries using PCV10/13 for at least 5-7 years with primary series uptake above 70% as mentioned in this paper.